Effect of immunization with the mannose-induced Acanthamoeba protein and Acanthamoeba plasminogen activator in mitigating Acanthamoeba keratitis

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 12, 2007, Pages 5597-5604

  Alizadeh, Hassan ^a   Neelam, Sudha ^a   Niederkorn, Jerry Y ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAROSE; CHOLERA TOXIN; FIBRIN; MANNOSE; MANNOSE INDUCED CYTOPATHIC PROTEIN 133; PLASMINOGEN ACTIVATOR; PROTOZOAL PROTEIN; UNCLASSIFIED DRUG; LIPOSOME; PROTOZOAL VACCINE; SECRETORY IMMUNOGLOBULIN;

ACANTHAMOEBA; ACANTHAMOEBA CASTELLANII; ACANTHAMOEBA KERATITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; CELL INFILTRATION; CHINESE HAMSTER; CHROMATOGRAPHY; COMBINATION CHEMOTHERAPY; CONTACT LENS; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA ULCER; CYTOLYSIS; DIFFUSION; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; DRUG CONJUGATION; DRUG ISOLATION; DRUG PURITY; EPITHELIUM CELL; FIBRINOLYSIS; IMMUNIZATION; IMMUNOPROPHYLAXIS; MONOTHERAPY; NONHUMAN; PATHOGENICITY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN INDUCTION; QUANTITATIVE ANALYSIS; TROPHOZOITE; ANIMAL; BIOSYNTHESIS; CORNEA; CRICETULUS; DISEASE MODEL; ENZYME LINKED IMMUNOSORBENT ASSAY; HAMSTER; IMMUNOLOGY; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; ORAL DRUG ADMINISTRATION; PARASITOLOGY;

ACANTHAMOEBA; ACANTHAMOEBA KERATITIS; ADMINISTRATION, ORAL; ANIMALS; CORNEA; CRICETINAE; CRICETULUS; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOGLOBULIN A, SECRETORY; INTESTINAL MUCOSA; LIPOSOMES; MANNOSE; PLASMINOGEN ACTIVATORS; PROTOZOAN PROTEINS; PROTOZOAN VACCINES;

EID: 38549116638     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.07-0407     Document Type: Article

References (35)

1. Niederkorn JY, Alizadeh H, Leher H, McCulley JP. The pathogenesis of Acanthamoeba keratitis. Microbes Infect. 1999;1:437-443.
2. Stehr-Green JK, Bailesy TM, Visvesvara GS. The epidemiology of Acanthamoeba keratitis in the United States. Am J Ophthalmol. 1989;107:331-336.
3. Moore MB, McCulley JP, Luckenbach M, et al. Acanthamoeba keratitis associated with soft contact lenses. Am J Ophthalmol. 1985;100:396-403.
4. Koenig SB, Solomon JM, Hyndiuk RA, Sucher RA, Gradus MS. Acanthamoeba keratitis associated with gas-permeable contact lens wear. Am J Ophthalmol. 1987;103:832.
5. Panjwani N, Zhao Z, Baum J, Pereira M, Zaidi T. Acanthamoebae bind to glycolipids of rabbit corneal epithelium. Infect Immun. 1992;60:3460-3463.
6. Panjwani N, Zaidi TS, Gigstad JE, Jungalwala FB, Barza M, Baum J. Binding of Pseudomonas aeruginosa to neutral glycosphingolipids of rabbit corneal epithelium. Infect Immun. 1990;58:114-118.
7. Morton LD, McLaughlin GL, Whiteley HE. Adherence characteristics of three strains of Acanthamoeba. Rev Infect Dis. 1991;13(suppl 5):S424.
8. Cao Z, Jefferson DM, Panjwani N. Role of carbohydrate-mediated adherence in cytopathogenic mechanisms of Acanthamoeba. J Biol Chem. 1998;273:15838-15845.
9. Leher H, Silvany R, Alizadeh H, Huang J, Niederkorn JY. Mannose induces the release of cytopathic factors from Acanthamoeba castellanii. Infect Immun. 1998;66:5-10.
10. Mitra MM, Alizadeh H, Gerard RD, Niederkorn JY. Characterization of a plasminogen activator produced by Acanthamoeba castellanii. Mol Biochem Parasitol. 1995;73:157-164.
11. Hadas E, Mazur T. Biochemical markers of pathogenicity and virulence of Acanthamoeba sp. strains. Parasitol Res. 1993;9:696-698.
12. Mitro K, Bhagavathiammai A, Zhou OM, et al. Partial characterization of the proteolytic secretions of Acanthamoeba polyphaga. Exp Parasitol. 1994;78:377-385.
13. He YG, Niederkorn JY, McCulley JP, et al. In vivo and in vitro collagenolytic activity of Acanthamoeba castellanii. Invest Ophthalmol Vis Sci. 1990;31:2235-2240.
14. Jaison PL, Cao Z, Panjwani N. Binding of Acanthamoeba to [corrected] mannose-glycoproteins of corneal epithelium: effect of injury. Curr Eye Res. 1998;17:770-776.
15. Garate M, Alizadeh H, Neelam S, Niederkorn JY, Panjwani N. Oral immunization with Acanthamoeba castellanii mannose-binding protein ameliorates amoebic keratitis. Infect Immun. 2006;74:7032-7034.
16. Leher HF, Alizadeh H, Taylor WM, et al. Role of mucosal IgA in the resistance to Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1998;39:2666-2673.
17. Alizadeh H, He Y, McCulley JP, et al. Successful immunization against Acanthamoeba keratitis in a pig model. Cornea. 1995;14:180-186.
18. Leher H, Kinoshita K, Alizadeh H, Zaragoza FL, He Y, Niederkorn J. Impact of oral immunization with Acanthamoeba antigens on parasite adhesion and corneal infection. Invest Ophthalmol Vis Sci. 1998;39:2337-2343.
19. Hurt M, Niederkorn J, Alizadeh H. Effects of mannose on Acanthamoeba castellanii proliferation and cytolytic ability to corneal epithelial cells. Invest Ophthalmol Vis Sci. 2003;44:3424-3431.
20. Hurt M, Neelam S, Niederkorn J, Alizadeh H. Pathogenic Acanthamoeba spp secrete a mannose-induced cytolytic protein that correlates with the ability to cause disease. Infect Immun. 2003;71:6243-6255.
21. van Klink F, Taylor WM, Alizadeh H, Jager MJ, van Rooijen N, Niederkorn JY. The role of macrophages in Acanthamoeba keratitis. Invest Ophthalmol Vis Sci. 1996;37:1271-1281.
22. Visvesvara GS. Classification of Acanthamoeba. Rev Infect Dis. 1991;13(suppl 5):S369-S372.
23. Silvany RE, Dougherty JM, McCulley JP, Wood TS, Bowman RW, Moore MB. The effect of currently available contact lens disinfection systems on Acanthamoeba castellanii and Acanthamoeba polyphaga. Ophthalmology. 1990;97:286-290.
24. Wilson SE, Weng J, Blair S, He YG, Lloyd S. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci. 1995;36:32-40.
25. Alizadeh H, Ma D, Berman M, et al. Tissue-type plasminogen activator-induced invasion and metastasis of murine melanomas. Curr Eye Res. 1995;14:449-458.
26. Saksela O. Radial caseinolysis in agarose: a simple method for detection of plasminogen activator in the presence of inhibitory substances and serum. Anal Biochem. 1981;111:276-282.
27. Hurt M, Apte S, Leher H, Howard K, Niederkorn J, Alizadeh H. Exacerbation of Acanthamoeba keratitis in animals treated with anti-macrophage inflammatory protein 2 or antineutrophil antibodies. Infect Immun. 2001;69:2988-2995.
28. Van Rooijen N. The liposome-mediated macrophage 'suicide' technique. J Immunol Methods. 1989;124:1-6.
29. van Klink F, Alizadeh H, Stewart GL, et al. Characterization and pathogenic potential of a soil isolate and an ocular isolate of Acanthamoeba castellanii in relation to Acanthamoeba keratitis. Curr Eye Res. 1992;11:1207-1220.
30. McKerrow JH, Newport G, Fishelson Z. Recent insights into the structure and function of a larval proteinase involved in host infection by a multicellular parasite. Proc Soc Exp Biol Med. 1991;197:119-124.
31. Dano K, Andreasen PA, Grondahl-Hansen J, Kristensen P, Nielsen LS, Skriver L. Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res. 1985;44:139-266.
32. Howe DK, Vodkin MH, Novak RJ, Visvesvara G, McLaughlin GL. Identification of two genetic markers that distinguish pathogenic and nonpathogenic strains of Acanthamoeba spp. Parasitol Res. 1997;83:345-348.
33. Mestecky J. The common mucosal immune system and current strategies for induction of immune responses in external secretions. J Clin Immunol. 1987;7:265-276.
34. Peppard JV, Mann RV, Montgomery PC. Antibody production in rats following ocular-topical or gastrointestinal immunization: kinetics of local and systemic antibody production. Curr Eye Res. 1988;7:471-481.
35. Alizadeh H, Apte S, El-Agha MS, et al. Tear IgA and serum IgG antibodies against Acanthamoeba in patients with Acanthamoeba keratitis. Cornea 2001;20:622-627.